Shire to License Rights for Pfizer’s IBD Drug PF-00547659
News
The biotechnology company Shire will license global rights from Pfizer for PF-00547659, a drug under development for patients with moderate-to-severe inflammatory bowel disease (IBD). IBD is a group of conditions characterized by inflammation in the ... Read more